Risk of stroke, gangrene from ergot drug interactions.
Article Details
- CitationCopy to clipboard
Wooltorton E
Risk of stroke, gangrene from ergot drug interactions.
CMAJ. 2003 Apr 15;168(8):1015.
- PubMed ID
- 12695387 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Dihydroergocornine Cytochrome P450 3A4 Protein Humans NoSubstrateDetails Dihydroergocristine Cytochrome P450 3A4 Protein Humans NoSubstrateDetails Dihydroergocryptine Cytochrome P450 3A4 Protein Humans NoSubstrateDetails Ergotamine Cytochrome P450 3A4 Protein Humans UnknownSubstrateInhibitorDetails - Drug Interactions
Drugs Interaction Integrate drug-drug
interactions in your softwareAlmotriptanCabergoline Cabergoline may increase the vasoconstricting activities of Almotriptan. AlmotriptanMethylergometrine Methylergometrine may increase the vasoconstricting activities of Almotriptan. AlmotriptanLisuride Lisuride may increase the vasoconstricting activities of Almotriptan. AlmotriptanNicergoline Nicergoline may increase the vasoconstricting activities of Almotriptan. AlmotriptanErgoloid mesylate Ergoloid mesylate may increase the vasoconstricting activities of Almotriptan.